Leelamine suppresses cMyc expression in prostate cancer cells in vitro and inhibits prostate carcinogenesis in vivo.
Krishna B SinghEun-Ryeong HahmShivendra V Singh
Published in: Journal of cancer metastasis and treatment (2021)
The present study reveals that LLM inhibits cMyc expression in human prostate cancer cells in vitro but concentrations higher than 10 mg/kg may be required to achieve chemoprevention of prostate cancer.